Last $145.49 USD
Change Today 0.00 / 0.00%
Volume 0.0
BAYZF On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
As of 8:10 PM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYZF) Key Developments

Bayer and Gedeon Richter Announce Major Co-Operation Deal on Distribution of Contraceptive Patch in Europe

Gedeon Richter has entered into a licensing and distribution agreement with Bayer for the latter's low-dose gestodene and ethinyl-estradiol containing transdermal contraceptive patch, to be marketed in the European Union, other European countries, and certain Latin American countries under the brand name Lisvy. Richter is due to make an upfront payment to Bayer on signing the contract, as well as additional milestone payments, dependent on the product's progress in commercialisation. Further sales royalties will be payable to Bayer after launch.

Bayer AG Presents at Commerzbank German Investment Seminar, Jan-12-2015

Bayer AG Presents at Commerzbank German Investment Seminar, Jan-12-2015 . Venue: New York, New York, United States.

Bayer Names Steven Immergut as New Head of Communications for its Pharmaceutical Business

Bayer has appointed Steven Immergut as new head of communications for its pharmaceutical business in the US. Steven Immergut has been hired in the newly created role of VP, head of pharmaceutical communications where he will lead the design, management and execution of the company's external and internal communications in the region.

Proteros Signs Research Cooperation Agreement with Bayer

Proteros announced that it signed a research cooperation agreement with Bayer aimed at identifying new agents for the treatment of cardiovascular diseases. Under the agreement, Proteros will be carrying out the research on a regulating membrane protein over a period of two years in order to achieve defined milestones, while Bayer will be responsible for the optimisation of pre-clinical candidates and clinical development. Proteros will receive payments for its R&D activities as well as milestone payments and royalties from the sale of potential commercial products.

Bayer AG Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM

Bayer AG Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 01:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Olivier Brandicourt, Chief Executive Officer of Bayer Healthcare and Chairman of The Management Board of Bayer Healthcare.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYZF:US $145.49 USD 0.00

BAYZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $60.93 USD -2.19
Amgen Inc $153.89 USD -2.48
AstraZeneca PLC 4,743 GBp -18.50
Celgene Corp $120.95 USD +0.08
Siemens AG €92.90 EUR -1.11
View Industry Companies
 

Industry Analysis

BAYZF

Industry Average

Valuation BAYZF Industry Range
Price/Earnings 26.1x
Price/Sales 2.3x
Price/Book 4.7x
Price/Cash Flow 26.1x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.